19 May 2013
Keywords: bioxell, takes, back, bxl746, roche, milan, italy-based
Article | 22 January 2007
Milan, Italy-based BioXell SpA has exercised the option to acquire the novel vitamin D3 analog, BXL746, from Swiss drug major ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 January 2007
17 May 2013
© 2013 thepharmaletter.com